Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)

[1]  T. Shi,et al.  m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway , 2023, Journal of experimental & clinical cancer research : CR.

[2]  Zhe Wang,et al.  Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer , 2023, Scientific Reports.

[3]  Xiangchou Yang,et al.  M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma , 2023, Vaccines.

[4]  Weihua Luo,et al.  m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner , 2023, Cell Death & Disease.

[5]  Xiao-Rong Liu,et al.  LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer , 2022, Frontiers in Oncology.

[6]  F. Huang,et al.  METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma , 2022, Frontiers in Cell and Developmental Biology.

[7]  Yingting Liu,et al.  Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients , 2022, World Journal of Surgical Oncology.

[8]  Yi Zhang,et al.  The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway , 2022, Molecular cancer.

[9]  K. Tao,et al.  METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma , 2022, Nature Cancer.

[10]  C. Pilarsky,et al.  An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer , 2022, Frontiers in Cell and Developmental Biology.

[11]  Guo Gao,et al.  METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5. , 2022, Cellular signalling.

[12]  W. Wang,et al.  N6 ‐methyladenosine RNA demethylase FTO regulates extracellular matrix‐related genes and promotes pancreatic cancer cell migration and invasion , 2022, Cancer medicine.

[13]  Ji-li Xu.  Wilms Tumor 1-Associated Protein Expression Is Linked to a T-Cell-Inflamed Phenotype in Pancreatic Cancer , 2022, Digestive Diseases and Sciences.

[14]  H. Eguchi,et al.  N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma , 2022, Scientific Reports.

[15]  Colin G. Cameron,et al.  Remediating Desmoplasia with EGFR‐Targeted Photoactivable Multi‐Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer , 2022, Advanced science.

[16]  Degang Kong,et al.  N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer , 2022, Bioengineered.

[17]  Peng-Chieh Chen,et al.  RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer , 2022, Oncogene.

[18]  Yi Huang,et al.  SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine. , 2022, Cell reports.

[19]  Xin Tian,et al.  Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products , 2022, Frontiers in Pharmacology.

[20]  Jana Jeschke,et al.  Why novel mRNA modifications are so challenging and what we can do about it , 2022, Nature Reviews Molecular Cell Biology.

[21]  Wei Wang,et al.  m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2 , 2022, Epigenetics.

[22]  Ronglin Wang,et al.  Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy , 2022, Frontiers in Oncology.

[23]  P. Yi,et al.  Targeting the RNA m6A modification for cancer immunotherapy , 2022, Molecular cancer.

[24]  Qiong Wu,et al.  Prognostic signature based on m6A-related lncRNAs to predict overall survival in pancreatic ductal adenocarcinoma , 2022, Scientific Reports.

[25]  Dan Wang,et al.  Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer , 2022, Journal of oncology.

[26]  Wanqing Chen,et al.  Cancer statistics in China and United States, 2022: profiles, trends, and determinants , 2022, Chinese medical journal.

[27]  Liangjing Zhou,et al.  ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer. , 2022, Cancer letters.

[28]  Hua Huang,et al.  Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c‑Myc translation. , 2021, International journal of oncology.

[29]  Qun Chen,et al.  Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma , 2021, Frontiers in Immunology.

[30]  Huihui Hao,et al.  ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling , 2021, Cell Death & Disease.

[31]  L. Cantley,et al.  Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer , 2021, Nature Reviews Clinical Oncology.

[32]  Ronglin Wang,et al.  Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer , 2021, Frontiers in Immunology.

[33]  Zhi-wen Zhang,et al.  RNA m6A Demethylase ALKBH5 Protects Against Pancreatic Ductal Adenocarcinoma via Targeting Regulators of Iron Metabolism , 2021, Frontiers in Cell and Developmental Biology.

[34]  S. Pauklin,et al.  Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches , 2021, Cancers.

[35]  R. Flavell,et al.  METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells , 2021, Nature Communications.

[36]  Yuanhong Xu,et al.  Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma , 2021, BMC Cancer.

[37]  Muhammad Zeeshan,et al.  Current controversies and advances in the management of pancreatic adenocarcinoma , 2021, World journal of gastrointestinal oncology.

[38]  Huaizhi Wang,et al.  N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction , 2021, International journal of biological sciences.

[39]  A. Azmi,et al.  Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside , 2021, Cancers.

[40]  Chuan He,et al.  Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response , 2021, Nucleic acids research.

[41]  Qingkai Meng,et al.  Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer , 2021, Frontiers in Oncology.

[42]  Ling Lin,et al.  m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD , 2021, Molecular therapy. Nucleic acids.

[43]  Yufei Lan,et al.  The role of M6A modification in the regulation of tumor-related lncRNAs , 2021, Molecular therapy. Nucleic acids.

[44]  E. Nakakura,et al.  Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[45]  H. Putter,et al.  A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial , 2021, EBioMedicine.

[46]  Yuting He,et al.  Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer , 2021, Bioscience reports.

[47]  Yiping Chen,et al.  N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma , 2021, Scientific Reports.

[48]  Tsutomu Suzuki.  The expanding world of tRNA modifications and their disease relevance , 2021, Nature Reviews Molecular Cell Biology.

[49]  Pengyuan Yang,et al.  RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming , 2021, Nature Communications.

[50]  M. Schaefer.  The Regulation of RNA Modification Systems: The Next Frontier in Epitranscriptomics? , 2021, Genes.

[51]  R. Dash,et al.  The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy , 2021, Frontiers in Oncology.

[52]  G. Shan,et al.  CircRNA in cancer: Fundamental mechanism and clinical potential. , 2021, Cancer letters.

[53]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[54]  A. Kourtidis,et al.  LNCcation: lncRNA localization and function , 2021, The Journal of cell biology.

[55]  S. Blanco,et al.  The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities , 2021, Molecular Cancer.

[56]  Bo Zhang,et al.  Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment , 2021, Theranostics.

[57]  Hui Shen,et al.  The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. , 2021, EBioMedicine.

[58]  R. Xu,et al.  Circular RNA: metabolism, functions and interactions with proteins , 2020, Molecular Cancer.

[59]  J. Rich,et al.  Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase , 2020, bioRxiv.

[60]  Xiaohan Cui,et al.  Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer , 2020, BMC Cancer.

[61]  Chuan He,et al.  Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer , 2020, Molecular Cancer.

[62]  F. Setién,et al.  Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer , 2020, Proceedings of the National Academy of Sciences.

[63]  Lianfang Zheng,et al.  Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC). , 2020, Cancer letters.

[64]  L. Zou,et al.  m5C modification of mRNA serves a DNA damage code to promote homologous recombination , 2020, Nature Communications.

[65]  David R. Liu,et al.  Programmable m6A modification of cellular RNAs with a Cas13-directed methyltransferase , 2020, Nature Biotechnology.

[66]  Yun Feng,et al.  RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner , 2020, Molecular Cancer.

[67]  E. Jaffee,et al.  The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities , 2020, Nature Reviews Clinical Oncology.

[68]  S. Chan,et al.  CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942 , 2020, Cancer Research.

[69]  M. Karamouzis,et al.  Immunotherapy for pancreatic cancer: A 2020 update. , 2020, Cancer treatment reviews.

[70]  Sung Ho Boo,et al.  The emerging role of RNA modifications in the regulation of mRNA stability , 2020, Experimental & Molecular Medicine.

[71]  X. Miao,et al.  Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. , 2020, The international journal of biochemistry & cell biology.

[72]  Yuting He,et al.  Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma , 2020, Scientific Reports.

[73]  F. Shimamoto,et al.  m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling , 2020, Molecular Cancer.

[74]  Yuanting Gu,et al.  Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway , 2019, Journal of Experimental & Clinical Cancer Research.

[75]  Heshui Wu,et al.  Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210 , 2019, Cellular Oncology.

[76]  Y. Miao,et al.  The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. , 2019, Pathology, research and practice.

[77]  Joshua D. Jones,et al.  Pseudouridinylation of mRNA coding sequences alters translation , 2019, Proceedings of the National Academy of Sciences.

[78]  Hailing Shi,et al.  Regulation of Co-transcriptional Pre-mRNA Splicing by m6A through the Low-Complexity Protein hnRNPG. , 2019, Molecular cell.

[79]  S. Jaffrey,et al.  Reading, writing and erasing mRNA methylation , 2019, Nature Reviews Molecular Cell Biology.

[80]  Dan Xie,et al.  5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs , 2019, Nature Cell Biology.

[81]  Schraga Schwartz,et al.  Deciphering the “m6A Code” via Antibody-Independent Quantitative Profiling , 2019, Cell.

[82]  Marc Graille,et al.  The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112 , 2019, Nucleic acids research.

[83]  Xiao-Min Liu,et al.  Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates , 2019, Nature Chemical Biology.

[84]  J. Haybaeck,et al.  The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer , 2019, International journal of molecular sciences.

[85]  Y. Pommier,et al.  Targeting Topoisomerase I in the Era of Precision Medicine , 2019, Clinical Cancer Research.

[86]  Joon-Oh Park,et al.  Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. , 2019, The New England journal of medicine.

[87]  L. You,et al.  WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer. , 2019, Cancer letters.

[88]  W. Tan,et al.  Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression , 2019, Nature Communications.

[89]  Lijia Ma,et al.  Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation , 2019, Nature Communications.

[90]  W. Miller,et al.  A review of cancer immunotherapy: from the past, to the present, to the future. , 2019, Current oncology.

[91]  W. Lou,et al.  PD-1 immunotherapy in pancreatic cancer: current status , 2019, Journal of Pancreatology.

[92]  J. Mauer,et al.  FTO controls reversible m6Am RNA methylation during snRNA biogenesis , 2019, Nature Chemical Biology.

[93]  Prashanth Rawla,et al.  Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors , 2019, World journal of oncology.

[94]  M. Bohnsack,et al.  Eukaryotic 5-methylcytosine (m5C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease , 2019, Genes.

[95]  I. Sahin,et al.  Pancreatic cancer microenvironment: a current dilemma , 2019, Clinical and Translational Medicine.

[96]  G. Haddad,et al.  The hypoxic kidney: pathogenesis and noncoding RNA-based therapeutic strategies. , 2019, Swiss medical weekly.

[97]  Thierry Lecomte,et al.  FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer , 2018, The New England journal of medicine.

[98]  Zhike Lu,et al.  Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs , 2018, Nucleic acids research.

[99]  Zhike Lu,et al.  N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation , 2018, Nature Chemical Biology.

[100]  David Sturgill,et al.  Acetylation of Cytidine in mRNA Promotes Translation Efficiency , 2018, Cell.

[101]  Y. Kim,et al.  ALKBH5 gene is a novel biomarker that predicts the prognosis of pancreatic cancer: A retrospective multicohort study , 2018, Annals of hepato-biliary-pancreatic surgery.

[102]  Sicong Zhang.  Mechanism of N6-methyladenosine modification and its emerging role in cancer. , 2018, Pharmacology & therapeutics.

[103]  Kwok-Kin Wong,et al.  mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis , 2018, Nature.

[104]  Gang Yang,et al.  Tumor microenvironment participates in metastasis of pancreatic cancer , 2018, Molecular Cancer.

[105]  Y. Miao,et al.  ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation , 2018, Cellular Physiology and Biochemistry.

[106]  J. Szostak,et al.  Mettl1/Wdr4-Mediated m7G tRNA Methylome Is Required for Normal mRNA Translation and Embryonic Stem Cell Self-Renewal and Differentiation. , 2018, Molecular cell.

[107]  Yinsheng Wang,et al.  Identification of YTH Domain-Containing Proteins as the Readers for N1-Methyladenosine in RNA. , 2018, Analytical chemistry.

[108]  B. Gregory,et al.  Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development , 2018, PLoS genetics.

[109]  S. Batra,et al.  Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential , 2018, Genes & cancer.

[110]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[111]  H. Ishii,et al.  The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. , 2017, International journal of oncology.

[112]  F. Du,et al.  YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells , 2017, Cell cycle.

[113]  C. Lenz,et al.  Human METTL16 is a N6‐methyladenosine (m6A) methyltransferase that targets pre‐mRNAs and various non‐coding RNAs , 2017, EMBO reports.

[114]  Schraga Schwartz,et al.  The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution , 2017, Nature.

[115]  Chuan He,et al.  N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis , 2017, Nature Structural &Molecular Biology.

[116]  Benjamin L. Musher,et al.  Oncolytic viral therapy for pancreatic cancer , 2017, Journal of surgical oncology.

[117]  Tao Pan,et al.  Dynamic RNA Modifications in Gene Expression Regulation , 2017, Cell.

[118]  Samie R Jaffrey,et al.  Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1 , 2017, Nature Communications.

[119]  Y. Mo,et al.  LncRNA-mediated regulation of cell signaling in cancer , 2017, Oncogene.

[120]  Samir Adhikari,et al.  5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader , 2017, Cell Research.

[121]  Zhike Lu,et al.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.

[122]  N. Rajewsky,et al.  Translation of CircRNAs , 2017, Molecular cell.

[123]  Yang Zhang,et al.  Extensive translation of circular RNAs driven by N6-methyladenosine , 2017, Cell Research.

[124]  Nian Liu,et al.  N 6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein , 2017, Nucleic acids research.

[125]  Chuan He,et al.  m6A RNA methylation regulates the UV-induced DNA damage response , 2017, Nature.

[126]  K. Harada,et al.  AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells , 2017, Scientific Reports.

[127]  Tao Pan,et al.  RNA modifications and structures cooperate to guide RNA–protein interactions , 2017, Nature Reviews Molecular Cell Biology.

[128]  Yun-Gui Yang,et al.  Cytoplasmic m6A reader YTHDF3 promotes mRNA translation , 2017, Cell Research.

[129]  Chuan He,et al.  FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. , 2017, Cancer cell.

[130]  Chengqi Yi,et al.  Epitranscriptome sequencing technologies: decoding RNA modifications , 2016, Nature Methods.

[131]  Olivier Elemento,et al.  Reversible methylation of m6Am in the 5′ cap controls mRNA stability , 2016, Nature.

[132]  K. Entian,et al.  Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function , 2016, RNA biology.

[133]  Chuan He,et al.  Post-transcriptional gene regulation by mRNA modifications , 2016, Nature Reviews Molecular Cell Biology.

[134]  Arne Klungland,et al.  ALKBH1-Mediated tRNA Demethylation Regulates Translation , 2016, Cell.

[135]  Ping Wang,et al.  Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. , 2016, Molecular cell.

[136]  W. Gilbert,et al.  Messenger RNA modifications: Form, distribution, and function , 2016, Science.

[137]  Qiang Wang,et al.  Structural basis of N6-adenosine methylation by the METTL3–METTL14 complex , 2016, Nature.

[138]  Kai Wang,et al.  Regulation of lncRNA and Its Role in Cancer Metastasis , 2016, Oncology research.

[139]  Chuanzhao Zhang,et al.  Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA , 2016, Proceedings of the National Academy of Sciences.

[140]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[141]  Gideon Rechavi,et al.  The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA , 2016, Nature.

[142]  K. Offit,et al.  Identification of germline genetic mutations in patients with pancreatic cancer , 2015, Cancer.

[143]  Olivier Elemento,et al.  5′ UTR m6A Promotes Cap-Independent Translation , 2015, Cell.

[144]  Saeed Tavazoie,et al.  HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events , 2015, Cell.

[145]  Haimin Li,et al.  Circular RNA: A new star of noncoding RNAs. , 2015, Cancer letters.

[146]  Chuan He,et al.  N 6 -methyladenosine Modulates Messenger RNA Translation Efficiency , 2015, Cell.

[147]  Michael A. Choti,et al.  Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets , 2015, Nature Communications.

[148]  K. Reddy.  MicroRNA (miRNA) in cancer , 2015, Cancer Cell International.

[149]  T. Steitz,et al.  Structural insights into the role of rRNA modifications in protein synthesis and ribosome assembly , 2015, Nature Structural &Molecular Biology.

[150]  Andreas W. Schreiber,et al.  The RNA Binding Protein Quaking Regulates Formation of circRNAs , 2015, Cell.

[151]  J. Kench,et al.  Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.

[152]  G. Shan,et al.  Exon-intron circular RNAs regulate transcription in the nucleus , 2015, Nature Structural &Molecular Biology.

[153]  Howard Y. Chang,et al.  Structure and thermodynamics of N6-methyladenosine in RNA: a spring-loaded base modification. , 2015, Journal of the American Chemical Society.

[154]  J. Rinn,et al.  Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution , 2015, Genome Biology.

[155]  M. Helm,et al.  Pseudouridine: Still mysterious, but never a fake (uridine)! , 2014, RNA biology.

[156]  Markus Blatter,et al.  Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA , 2014, Nucleic acids research.

[157]  Guodong Yang,et al.  LncRNA: a link between RNA and cancer. , 2014, Biochimica et biophysica acta.

[158]  Li Liu,et al.  Regulation of lncRNA expression , 2014, Cellular & Molecular Biology Letters.

[159]  N. Rajewsky,et al.  circRNA biogenesis competes with pre-mRNA splicing. , 2014, Molecular cell.

[160]  Liang Tong,et al.  Molecular basis for the recognition of methylated adenines in RNA by the eukaryotic YTH domain , 2014, Proceedings of the National Academy of Sciences.

[161]  W. Gilbert,et al.  Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells , 2014, Nature.

[162]  T. Hasan,et al.  Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer , 2014, British Journal of Cancer.

[163]  Miao Yu,et al.  A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation , 2013, Nature chemical biology.

[164]  A. Masamune,et al.  miR-210 regulates the interaction between pancreatic cancer cells and stellate cells. , 2013, Biochemical and biophysical research communications.

[165]  A. Jaiswal,et al.  miRNA–transcription factor interactions: a combinatorial regulation of gene expression , 2013, Molecular Genetics and Genomics.

[166]  Zhike Lu,et al.  ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. , 2013, Molecular cell.

[167]  K. Shimada,et al.  PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis. , 2012, Cancer research.

[168]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[169]  O. Elemento,et al.  Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons , 2012, Cell.

[170]  M. Kupiec,et al.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.

[171]  T. Preiss,et al.  Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA , 2012, Nucleic acids research.

[172]  Quynh-Thu Le,et al.  Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. , 2010, Translational oncology.

[173]  Frank Lyko,et al.  RNA cytosine methylation analysis by bisulfite sequencing , 2008, Nucleic acids research.

[174]  Marcin Feder,et al.  MODOMICS: a database of RNA modification pathways , 2005, Nucleic Acids Res..

[175]  N. L. Greenbaum,et al.  A conserved pseudouridine modification in eukaryotic U2 snRNA induces a change in branch-site architecture. , 2001, RNA.

[176]  WALDO E. COHN,et al.  Nucleoside-5′-Phosphates from Ribonucleic Acid , 1951, Nature.

[177]  Bijoyita Roy.  Effects of mRNA Modifications on Translation: An Overview. , 2021, Methods in molecular biology.

[178]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[179]  Y. Baran,et al.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment. , 2021, Methods in molecular biology.

[180]  Vespasiani-Gentilucci,et al.  Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes , 2018 .

[181]  U. Laufs,et al.  Circular RNA Splicing. , 2018, Advances in experimental medicine and biology.

[182]  B. Gloss,et al.  The specificity of long noncoding RNA expression. , 2016, Biochimica et biophysica acta.

[183]  M. Ivan,et al.  miR-210: fine-tuning the hypoxic response. , 2014, Advances in experimental medicine and biology.

[184]  J. Alfonzo,et al.  Transfer RNA modifications: nature's combinatorial chemistry playground , 2013, Wiley interdisciplinary reviews. RNA.

[185]  D. Davis.  Stabilization of RNA stacking by pseudouridine. , 1995, Nucleic acids research.